| David A. Lamond |
|
4460154 |
0 |
4460154 |
0 |
4460154 |
10.1 % |
13/11/2024 |
| Richter (“Richter”) |
Citizen |
2178150 |
0 |
2178150 |
0 |
2178150 |
5.1 % |
12/02/2024 |
| Papiernik (“Papiernik”) |
Citizen |
2178150 |
0 |
2178150 |
0 |
2178150 |
5.1 % |
12/02/2024 |
| Seghezzi (“Seghezzi”) |
Citizen |
2178150 |
0 |
2178150 |
0 |
2178150 |
5.1 % |
12/02/2024 |
| Partners SAS, a French corporation (“SP SAS”) |
France |
2178150 |
0 |
2178150 |
0 |
2178150 |
5.1 % |
12/02/2024 |
| Capital VIII (“SC VIII”) |
France |
2178150 |
0 |
2178150 |
0 |
2178150 |
5.1 % |
12/02/2024 |
| Bhaman (“Bhaman”) |
Citizen |
2178150 |
0 |
2178150 |
0 |
2178150 |
5.1 % |
12/02/2024 |
| Francesco Micheli |
Italy |
0 |
2525950 |
0 |
0 |
2525950 |
5.89 % |
14/12/2023 |
| Genextra S.p.A. |
Italy |
0 |
2525950 |
2525950 |
0 |
2525950 |
5.89 % |
14/12/2023 |
| Matteo Bruno Renzulli |
Italy |
0 |
2525950 |
0 |
0 |
2525950 |
5.89 % |
14/12/2023 |
| BML Investment Partners, L.P. |
Delaware |
0 |
1466201 |
0 |
1466201 |
1466201 |
4.04 % |
17/07/2023 |
| Braden M Leonard |
Delaware |
375100 |
1466201 |
375100 |
1466201 |
1841301 |
5.07 % |
17/07/2023 |
| 95-1411037 |
Delaware |
0 |
0 |
0 |
0 |
13 |
0 % |
08/07/2022 |
| Pfizer Inc. 13-5315170 |
|
0 |
600000 |
0 |
0 |
600000 |
2.01 % |
11/02/2022 |
| (VOLUNTARY) 98-1625216 |
|
0 |
600000 |
0 |
0 |
600000 |
2.01 % |
11/02/2022 |
| 95-1411037 |
Delaware |
2501882 |
0 |
2501882 |
0 |
13 |
8.4 % |
11/02/2022 |
| 95-1411037 |
Delaware |
0 |
0 |
0 |
0 |
13 |
0 % |
11/02/2022 |
| 95-1411037 |
Delaware |
1462465 |
0 |
1462465 |
0 |
13 |
4.9 % |
10/12/2021 |
| 95-1411037 |
Delaware |
1462465 |
0 |
1462465 |
0 |
13 |
4.9 % |
10/12/2021 |
| 95-1411037 |
Delaware |
2976489 |
0 |
2976489 |
0 |
13 |
10 % |
08/10/2021 |
| 95-1411037 |
Delaware |
2976489 |
0 |
2976489 |
0 |
13 |
10 % |
08/10/2021 |
| David A. Lamond |
United States of America |
2048938 |
0 |
2048938 |
0 |
2048938 |
6.9 % |
27/04/2021 |
| ( 82-5524518 |
Delaware |
0 |
1586475 |
0 |
0 |
1586475 |
5.4 % |
25/03/2021 |
| ( 81-4334429 |
Delaware |
0 |
215697 |
0 |
0 |
215697 |
0.7 % |
25/03/2021 |
| ( 13-5315170 |
Delaware |
254205 |
1802172 |
254205 |
0 |
2056377 |
7 % |
25/03/2021 |
| 95-1411037 |
Delaware |
3170731 |
0 |
3170731 |
0 |
13 |
10.7 % |
10/03/2021 |
| 95-1411037 |
Delaware |
2580455 |
0 |
2580455 |
0 |
13 |
8.7 % |
16/02/2021 |
| 95-1411037 |
Delaware |
2580455 |
0 |
2580455 |
0 |
13 |
8.7 % |
16/02/2021 |
| 95-1411037 |
Delaware |
2605753 |
0 |
2605753 |
0 |
13 |
8.8 % |
16/02/2021 |
| 95-1411037 |
Delaware |
2610237 |
0 |
2610237 |
0 |
13 |
8.8 % |
16/02/2021 |
| ( 81-4334429 |
Delaware |
0 |
215697 |
0 |
0 |
215697 |
0.7 % |
12/02/2021 |
| ( 82-5524518 |
Delaware |
0 |
1673470 |
0 |
0 |
1673470 |
5.7 % |
12/02/2021 |
| ( 13-5315170 |
Delaware |
254205 |
1889167 |
254205 |
0 |
2143372 |
7.3 % |
12/02/2021 |
| Chad Boeding |
DELAWARE |
176787 |
2863096 |
176787 |
0 |
2863096 |
9.71 % |
01/02/2021 |
| EPIQ Capital Group, LLC |
DELAWARE |
0 |
2686309 |
0 |
0 |
2686309 |
9.11 % |
01/02/2021 |
| CTEPQ Partners LLC |
DELAWARE |
936309 |
0 |
936309 |
0 |
936309 |
3.17 % |
01/02/2021 |
| EPQ LLC, CTYM PS |
DELAWARE |
1750000 |
0 |
1750000 |
0 |
1750000 |
5.93 % |
01/02/2021 |
| Takeda Pharmaceuticals U.S.A., Inc. |
United States |
0 |
87258 |
0 |
0 |
87258 |
0.3 % |
28/01/2021 |
| Takeda Pharmaceutical Company Limited |
United States |
0 |
87258 |
0 |
0 |
87258 |
2 % |
28/01/2021 |
| Takeda Ventures, Inc. |
United States |
0 |
87258 |
0 |
0 |
87258 |
0.3 % |
28/01/2021 |
| Takeda Pharmaceuticals International AG |
United States |
0 |
23821 |
0 |
0 |
23821 |
0.1 % |
28/01/2021 |
| Capital Research Global Investors ** |
|
2442914 |
0 |
2442914 |
0 |
2442914 |
9 % |
14/02/2020 |
| EPIQ Capital Group, LLC |
DELAWARE |
0 |
2686309 |
0 |
0 |
2686309 |
10 % |
07/01/2020 |
| Chad Boeding |
DELAWARE |
140487 |
2686309 |
140487 |
0 |
2826796 |
10.53 % |
07/01/2020 |
| EPQ LLC, CTYM PS |
DELAWARE |
1750000 |
0 |
1750000 |
0 |
1750000 |
6.52 % |
07/01/2020 |
| CTEPQ Partners LLC |
DELAWARE |
936309 |
0 |
936309 |
0 |
936309 |
3.49 % |
07/01/2020 |
| 10.75% |
United States of America |
1924020 |
0 |
1924020 |
962510 |
2886530 |
10.75 % |
30/09/2019 |
| 1,925,165 |
United States of America |
1925165 |
0 |
1925165 |
0 |
1925165 |
7.17 % |
30/09/2019 |
| EPQ LLC, CTYM PS |
DELAWARE |
1750000 |
0 |
1750000 |
0 |
1750000 |
6.56 % |
18/06/2019 |
| CTEPQ Partners LLC |
DELAWARE |
936309 |
0 |
936309 |
0 |
936309 |
3.51 % |
18/06/2019 |
| Chad Boeding |
DELAWARE |
140487 |
2686309 |
140487 |
0 |
2826796 |
10.6 % |
18/06/2019 |
| EPIQ Capital Group, LLC |
DELAWARE |
0 |
2686309 |
0 |
0 |
2686309 |
10.07 % |
18/06/2019 |
| EPIQ Capital Group, LLC |
DELAWARE |
0 |
2826157 |
0 |
0 |
2826157 |
10.07 % |
11/06/2019 |
| CTEPQ Partners LLC |
DELAWARE |
936309 |
0 |
936309 |
0 |
936309 |
3.51 % |
11/06/2019 |
| Chad Boeding |
DELAWARE |
139848 |
2826157 |
139848 |
0 |
2826157 |
10.59 % |
11/06/2019 |
| EPQ LLC, CTYM PS |
DELAWARE |
1750000 |
0 |
1750000 |
0 |
1750000 |
6.56 % |
11/06/2019 |
| ( 81-4334429 |
Delaware |
0 |
215697 |
0 |
0 |
215697 |
0.8 % |
22/05/2019 |
| ( 13-5315170 |
Delaware |
624205 |
2625768 |
624205 |
0 |
3249973 |
12.2 % |
22/05/2019 |
| ( 82-5524518 |
Delaware |
0 |
2410071 |
0 |
0 |
2410071 |
9 % |
22/05/2019 |
| Takeda Pharmaceutical Company Limited |
Switzerland |
0 |
2679802 |
0 |
2679802 |
2679802 |
9.9 % |
20/05/2019 |
| Takeda Pharmaceuticals U.S.A., Inc. |
Switzerland |
0 |
2679802 |
0 |
2679802 |
2679802 |
9.9 % |
20/05/2019 |
| Takeda Ventures, Inc. |
Switzerland |
0 |
2679802 |
0 |
2679802 |
2679802 |
9.9 % |
20/05/2019 |
| Takeda Pharmaceuticals International AG |
Switzerland |
0 |
1123105 |
0 |
1123105 |
1123105 |
4.2 % |
20/05/2019 |